Paul Verrastro
Sales & Marketing chez CVRX, INC.
Fortune : 5 595 $ au 31/05/2024
Profil
Paul Verrastro is currently the Director at MFr Technologies, Inc. and the Chief Marketing & Strategy Officer at CVRx, Inc. He previously worked as the Vice President-Global Strategic Marketing at Medtronic, Inc. from 2011 to 2021 and as the Vice President-Global Marketing at Guidant Corp.
He completed his undergraduate degree from Syracuse University School of Information Studies.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CVRX, INC.
0,00% | 09/04/2024 | 805 ( 0,00% ) | 5 595 $ | 31/05/2024 |
Postes actifs de Paul Verrastro
| Sociétés | Poste | Début |
|---|---|---|
| CVRX, INC. | Sales & Marketing | 01/01/2021 |
| MFr Technologies, Inc. (Minnesota) | Directeur/Membre du Conseil | - |
Anciens postes connus de Paul Verrastro
| Sociétés | Poste | Fin |
|---|---|---|
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | 01/01/2021 |
| Guidant Corp /Vascular Branch Therapy Business/ | Sales & Marketing | - |
Formation de Paul Verrastro
| Syracuse University School of Information Studies | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CVRX, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Guidant Corp /Vascular Branch Therapy Business/ | Health Technology |
| MFr Technologies, Inc. (Minnesota) | |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
